Post-COVID-19 Syndrome
Conditions
Brief summary
The goal of this clinical trial is to learn about the effectiveness of supportive psychotherapy in post covid-19 syndrome patients. The main questions it aims to answer are: 1. What is the effect of supportive psychotherapy on psychological and somatic symptoms in post covid-19 syndrome patients? 2. What is the effect of supportive psychotherapy on the neutrophil lymphocyte ratio in post covid-19 syndrome patients? 3. What is the effect of supportive psychotherapy on heart rate variability in post covid-19 syndrome patients? Participants will be given supportive psychotherapy in the form of an online group for 3 times a week with a duration of psychotherapy ranging from 1 - 2 hours per session. Researchers will compare the supportive psychotherapy group to education group as control. The control group will be given education about Post Covid-19 syndrome in the form of an online group for 3 times a week with a duration of around 1 - 2 hours per session.
Interventions
BEHAVIORALSupportive Psychotherapy
Supportive psychotherapy is a treatment that uses direct measures to ameliorate symptoms and to maintain, restore or improve self-esteem, ego function, and adaptive skills
Sponsors
Indonesia University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age 18 years or over * Patients confirmed positive for SARS CoV-2 by molecular testing (SARS CoV-2 RT-PCR, naso-oropharyngeal swab) at least 3 months before recruitment, with symptoms and effects lasting for at least 2 months and not explained by alternative diagnoses other * Patients with or without comorbidities: diabetes mellitus, hypertension, tuberculosis, asthma, chronic obstructive pulmonary disease, chronic kidney disease, heart disease, chronic liver disease, malignancy, nervous system disease, patients with vulnerability, patients with disabilities. * Patients can communicate and are willing to be interviewed, fill out questionnaires and psychotherapy. * The patient is willing to fill out and sign an informed 1 sheet of consent to participate in the study
Exclusion criteria
* Psychosis * Can not access internet for psychotherapy * Not willing to take part in the research
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pyschological and somatic symptoms | Change from baseline SCL-90 questionnaire at 1 week | Measured with SCL-90 questionnaire. Minimum score is 0, maximum score is 360. Higher scores mean worse outcome |
| Neutrophil Lymphocyte Ratio (NLR) | Change from baseline NLR at 1 week | Measured by calculating the value of the ratio of neutrophils and lymphocytes based on blood sampling |
| Heart Rate Variability | Change from baseline SDNN at 1 week | Measured by assessing SDNN by using Photoplethysmograph SA-3000P |
Countries
Indonesia
Outcome results
None listed